论文部分内容阅读
H~+—K~-—ATP酶抑制剂的开发是基于对泌酸机制深入的认识:从膜受体深入到壁细胞内部泌酸最后共同通路(H~-—K~-—ATP酶),从多种受体集中列关键性一步上,这类药物(以使用得最广泛的奥美拉唑Om为代表)的使用,还促进了我们对酸和消化性
The development of H ~ + -K ~ -ATPase inhibitor is based on the understanding of the mechanism of acid secretion: the last common pathway (H ~ - K ~ - ATPase) , The use of these drugs (represented by the most widely used omeprazole Om) at a crucial first step in a variety of receptor concentrations has also contributed to our understanding of acid and digestibility